Showing results (31-40 of 161) with videos related to
Sort By:
Pageof 17
Cancer Treatment Reviews|March 17, 2023
European expert panel consensus on the clinical management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancerErika Martinelli, Dirk Arnold, Andres Cervantes, et al.Journal of Clinical Medicine|February 11, 2021
Endorectal Ultrasound and Magnetic Resonance Imaging for Rectal Cancer Staging: A Modern Multimodality ApproachAlfonso Reginelli, Alfredo Clemente, Angelo Sangiovanni, et al.The Oncologist|December 1, 2025
Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer patients: demystifying the 100% clinical complete response paradigmFederica Marmorino, Federica Morano, Maria Anna Canciello, et al.World Journal of Gastroenterology|July 15, 2017
Implication of the Hedgehog pathway in hepatocellular carcinomaCarminia Maria Della Corte, Giuseppe Viscardi, Federica Papaccio, et al.Lung Cancer (Amsterdam, Netherlands)|July 13, 2010
RETRACTED: Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitorsFloriana Morgillo, Elena D'Aiuto, Teresa Troiani, et al.Cancer Treatment and Research Communications|August 14, 2021
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening?Gianluca Arrichiello, Luca Poliero, Carola Borrelli, et al.Future Oncology (London, England)|February 14, 2018
Computed tomography densitometric study of anti-angiogenic effect of regorafenib in colorectal cancer liver metastasisAlfonso Reginelli, Alfredo Clemente, Claudia Cardone, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibitionTeresa Troiani, Stefania Napolitano, Donata Vitagliano, et al.Future Oncology (London, England)|January 19, 2021
Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancerCarlo Barone, Maria Di Bartolomeo, Sara Lonardi, et al.Expert Opinion on Investigational Drugs|August 14, 2013
Metformin in lung cancer: rationale for a combination therapyFloriana Morgillo, Ferdinando Carlo Sasso, Carminia Maria Della Corte, et al.Pageof 17